A Bucks County woman is speaking out after her insurance company decided to no longer cover weight loss drugs.
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
This practice is not approved by the U.S. Food and Drug Administration (FDA). "Health care clinicians do not typically ...
In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...
For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.
CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early ...